NYCOLE OLIVER: Open Payments
NPI 1881074151 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,039 in 86 payments from 21 companies in 2025. Trend: 2023 $810 · 2024 $1,891 · 2025 $3,039
Food & beverage: $3,039
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $475 |
| Novo Nordisk Inc | 8 | $453 |
| ABBVIE INC. | 13 | $321 |
| Amgen Inc. | 10 | $265 |
| Stryker Corporation | 2 | $253 |
| PFIZER INC. | 10 | $250 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $160 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Corcept Therapeutics | 1 | $111 |
| Medtronic, Inc. | 1 | $109 |
Products named: BREZTRI, VRAYLAR, Wegovy, Ozempic, CAPLYTA, PRIME, ZAVZPRET, NURTEC ODT.
Industry payments across AR — which companies pay providers there.
